Stock
Pharming Group NV (PHAR), a biopharmaceutical company specializing in rare diseases, reported a solid third quarter in 2024, with significant growth in its product...
Hi, what are you looking for?
Pharming Group NV (PHAR), a biopharmaceutical company specializing in rare diseases, reported a solid third quarter in 2024, with significant growth in its product...
Investing.com — The $8.5 billion merger deal between US luxury groups Tapestry (NYSE:TPR) and Capri has been blocked by a US judge, in a win...
(Reuters) – UBS Global Wealth Management raised its stance on global equities to “attractive” from “neutral”, citing resilient U.S. economic growth and the monetary...
Investing.com – Indonesia stocks were lower after the close on Friday, as losses in the Financials, Infrastructure and Agriculture sectors led shares lower. At...
In the third quarter of 2024, X-FAB Silicon Wafers (ticker: X-FAB) reported a 12% year-on-year revenue decline to $206 million, which aligns with the...
In their third-quarter earnings call, Evolution Gaming Group AB (EVO:Stockholm) announced a solid performance with a total operating revenue of €579 million, marking a...
By Kate Abnett BRUSSELS (Reuters) – The leading U.N. body on climate change is experiencing a severe budget shortfall, according to a Reuters analysis...
WASHINGTON (Reuters) – The European Central Bank may need to ease policy somewhat faster than earlier thought but interest rates do not need to...
By Mike Dolan LONDON (Reuters) – If markets are correct, inflation-adjusted European Central Bank interest rates could be back negative by the middle of...
By Andrey Sychev (Reuters) -German premium automaker Mercedes-Benz (OTC:MBGAF) on Friday said third-quarter earnings in the core car division plunged by 64%, massively missing...